The type of tumor, stage of tumorigenesis, tumor microenvironment, genetic, epigenetic factors, NSAIDs pharmacokinetics profile, and selectivity of COX-I and COX-II inhibition may have an impact on anticancer activity. Here, MT-CO1 is linked to neoplasm.